(41) found that an elevated Alb-dNLR score was an independent prognostic factor for recurrence-free survival (RFS) in patients with locally advanced rectal cancer (LARC) treated with neoadjuvant chemoradiotherapy. This evidence concerns the gene ALB and rectal cancer.